Teva Pharmaceutical Industries (NYSE:TEVA)

Major Pharma Sees Fading Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Teva and Amgen Settle Over Kidney Disease Patent Infringement

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced on Thursday that it has settled with Amgen Inc. (NASDAQ: AMGN) for its treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AbbVie, Agilent, Albermarle, Apple, Boeing, Cheniere, First Solar, HCA, LabCorp, Lumber Liquidators, Teva and More

Stocks started 2019 on a mixed playing field on Wednesday, but Apple dropped a revenue and earnings warning after the close and that sent equity index futures down over 1% ...
Read Full Story »

Short Sellers Hike Bets in Major Pharma Stocks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Major Pharma Stocks See a Surge in Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Short Sellers Hike Their Bets in Major Pharma Stocks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

New Erectile Dysfunction Treatment Likely to Face Stiff Competition If Approved

The treatment of erectile dysfunction (ED) has helped literally tens of millions of men in America alone. The number of drugs treating ED has grown substantially over the years, and ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Adamas, Alibaba, Bluebird Bio, Chevron, Encana, Parsley Energy, Starbucks, Teva, Under Armour and More

Stocks were looking for direction on Monday morning ahead of Tuesday's midterms and with new sanctions placed on Iran. While last week's stock market bounce was handily off of the ...
Read Full Story »

The Drag on Teva’s Q3 Results

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) released its most recent earnings report before the markets opened on Thursday. The pharma giant said that it had $0.68 in earnings per share ...
Read Full Story »

Facebook, GE, Starbucks and More Major Earnings Coming This Week

The broad markets were crushed this past week, suffering roughly a 4% drop. While it seems that we are seeing a correction with the Dow Jones industrials and S&P 500 ...
Read Full Story »

Major Pharma Short Sellers Hike Their Bets

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Short Sellers Run for Cover From Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Amgen, Chipotle, Lam Research, Netgear, Teva Pharmaceutical, Western Digital and More

The futures traded up big Monday morning as we start the final quarter of 2018. With some of the distractions starting to move out of the way, and the Federal ...
Read Full Story »

Short Sellers Grow More Selective on Major Pharma Stocks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »